MLchartDataset catalogue

Istodax

Term · Oncology and biomedicine · MLC-T-ONC-004550

A drug used to treat adults with cutaneous T-cell lymphoma that has already been treated with at least one other type of systemic therapy. It is also being studied in the treatment of other types of cancer. Istodax blocks certain enzymes needed for cell division and may kill cancer cells. It is a type of depsipeptide and a type of histone deacetylase inhibitor. Also called FR901228 and romidepsin.

Table 1. Record
IdentifierMLC-T-ONC-004550
FieldOncology and biomedicine
SynonymsFR901228; romidepsin
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-004550",
  "term": "Istodax",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat adults with cutaneous T-cell lymphoma that has already been treated with at least one other type of systemic therapy. It is also being studied in the treatment of other types of cancer. Istodax blocks certain enzymes needed for cell division and may kill cancer cells. It is a type of depsipeptide and a type of histone deacetylase inhibitor. Also called FR901228 and romidepsin.",
  "synonyms": [
    "FR901228",
    "romidepsin"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/istodax/"
}

Record 9,633 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.